Efficacy of Prostate-Specific Antigen Screening: Use of Regression Discontinuity in the PLCO Cancer Screening Trial.
About this Publication
Title
Efficacy of Prostate-Specific Antigen Screening: Use of Regression Discontinuity in the PLCO Cancer Screening Trial.
Pubmed ID
26291583
(View this publication on the PubMed website)
Publication
JAMA Oncol. 2015 Oct; Volume 1 (Issue 7): Pages 984-6
Authors
Shoag J, Halpern J, Eisner B, Lee R, Mittal S, Barbieri CE, Shoag D
Affiliations
- Department of Urology, New York Presbyterian Hospital, Weill Cornell Medical College, New York.
- Department of Urology, Massachusetts General Hospital, Boston.
- Department of Public Policy, Harvard Kennedy School, Cambridge, Massachusetts.
Abstract
N/A
Related CDAS Studies
Related CDAS Projects
- PLCO-90: Use of Regression Discontinuity to Measure the Effect of PSA Screening (Jonathan Shoag - 2014)